A consistent view of the latest supported company value and reported operating results.
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is positive. As of 2026-06-30.
Trailing-twelve-month operating cash flow less capital expenditures is positive. As of 2026-06-30.
Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-06-30.
Comparable retained change history is not available through this reader.
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Completed-session reference prices from IEX for Oct 15, 2026.
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Five years of adjusted closing-price history for this listing, shown as historical context rather than a live quote.
The chart uses the market provider's adjusted daily close for the current listing. It does not stitch predecessor listings and does not represent total return, benchmark performance, or historical valuation.
Ticker: GMED · Exchange: NYSE · Globus Medical Class A Common Stock
SEC issuer CIK: 0001237831
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $3.14B Filed 2026-08-06 | $2.94B Filed 2026-02-24 | $2.52B Filed 2026-02-24 | $1.57B Filed 2026-02-24 | $1.02B Filed 2025-02-20 |
| Cost of revenue | $989.15M Filed 2026-08-06 | $957.8M Filed 2026-02-24 | $1.04B Filed 2026-02-24 | $548.17M Filed 2026-02-24 | $263.73M Filed 2025-02-20 |
| Gross profit | Unknown | Unknown | Unknown | $1.02B Filed 2024-02-21 | $759.12M Filed 2024-02-21 |
| Operating expenses | Unknown | Unknown | Unknown | $887.16M Filed 2024-02-21 | $531.17M Filed 2024-02-21 |
| Operating income | $639.52M Filed 2026-08-06 | $479.82M Filed 2026-02-24 | $165.99M Filed 2026-02-24 | $133.14M Filed 2026-02-24 | $227.95M Filed 2025-02-20 |
| Pretax income | $660.12M Filed 2026-08-06 | $605.07M Filed 2026-02-24 | $120.72M Filed 2026-02-24 | $165.39M Filed 2026-02-24 | $243.02M Filed 2025-02-20 |
| Income tax expense | $124.69M Filed 2026-08-06 | $67.2M Filed 2026-02-24 | $17.74M Filed 2026-02-24 | $42.52M Filed 2026-02-24 | $52.85M Filed 2025-02-20 |
| Net income | $535.43M Filed 2026-08-06 | $537.87M Filed 2026-02-24 | $102.98M Filed 2026-02-24 | $122.87M Filed 2026-02-24 | $190.17M Filed 2025-02-20 |
| Diluted EPS | Unavailable | $3.92 Filed 2026-02-24 | $0.75 Filed 2026-02-24 | $1.07 Filed 2026-02-24 | $1.85 Filed 2025-02-20 |
| Diluted shares | Unavailable | 137.06M Filed 2026-02-24 | 137.86M Filed 2026-02-24 | 114.63M Filed 2026-02-24 | 102.64M Filed 2025-02-20 |
| Metric | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash | $526.16M Filed 2026-02-24 | $784.44M Filed 2026-02-24 | Unknown | Unknown |
| Current assets | $2.13B Filed 2026-02-24 | $2.18B Filed 2026-02-24 | $1.92B Filed 2025-02-20 | $983.34M Filed 2024-02-21 |
| Current liabilities | $498.5M Filed 2026-02-24 | $855.91M Filed 2026-02-24 | $392.35M Filed 2025-02-20 | $159.2M Filed 2024-02-21 |
| Total assets | $5.3B Filed 2026-02-24 | $5.25B Filed 2026-02-24 | $5.09B Filed 2025-02-20 | $2.08B Filed 2024-02-21 |
| Total liabilities | $729.51M Filed 2026-02-24 | $1.07B Filed 2026-02-24 | $1.09B Filed 2025-02-20 | $229.75M Filed 2024-02-21 |
| Stockholders’ equity | $4.57B Filed 2026-02-24 | $4.18B Filed 2026-02-24 | $4B Filed 2026-02-24 | $1.85B Filed 2026-02-24 |
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | $910.39M Filed 2026-08-06 | $753.45M Filed 2026-02-24 | $520.64M Filed 2026-02-24 | $243.5M Filed 2026-02-24 | $178.47M Filed 2025-02-20 |
| Depreciation & amortization | $279.49M Filed 2026-08-06 | $276.84M Filed 2026-02-24 | $253.39M Filed 2026-02-24 | $145.53M Filed 2026-02-24 | $68.25M Filed 2025-02-20 |
| Capital expenditures | $154.8M Filed 2026-08-06 | $164.68M Filed 2026-02-24 | $115.43M Filed 2026-02-24 | $78.27M Filed 2026-02-24 | $74.05M Filed 2025-02-20 |
| Stock repurchases | $221.06M Filed 2026-08-06 | $300.45M Filed 2026-02-24 | $85.79M Filed 2026-02-24 | $225.56M Filed 2026-02-24 | $144.49M Filed 2025-02-20 |
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Reviewed current market-value multiples appear only when the matching denominator is supported.
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Beneficial-ownership snapshots, limited filing observations, and insider transactions are different facts. This view keeps them separate instead of reconstructing a position from transaction flow.
These filings are partial incremental or legacy observations. They can show what a filing reported, but they are not complete current-position snapshots and are not added together.
| Reporting owner | Scope | Reported positions | As of | Evidence |
|---|---|---|---|---|
| David Paul | Partial incremental | 1 | Dec 8, 2025 | Source ↗ |
Current beneficial ownership, transaction activity, institutional ownership, and connected-wealth relationships are separate source families. Institutional ownership is not part of this view.
Transaction security titles stay source-reported unless a reviewed legal-security mapping exists; Grizzly Bulls does not guess from similar names.
This is a reader-facing presentation of reviewed evidence. It does not create new rankings, alerts, change intelligence, narratives, or calculations.
Deterministic changes from supported reported financials, reviewed share-count history, and comparable reviewed ownership records. Events are ordered by when the supporting information became public, not by a Grizzly Bulls importance score.
Primary evidence: 10-Q · May 7, 2026 · 10-Q · Aug 6, 2026
Comparison evidence: 10-Q · May 8, 2025 · 10-Q · Aug 7, 2025
Primary evidence: 10-Q · May 7, 2026
Comparison evidence: 10-Q · May 8, 2025
Primary evidence: 10-K · Feb 24, 2026
Comparison evidence: 10-K · Feb 24, 2026
Primary evidence: 10-K · Feb 24, 2026
Comparison evidence: 10-K · Feb 24, 2026
Primary evidence: 10-K · Feb 24, 2026
Comparison evidence: 10-K · Feb 20, 2025
Primary evidence: 10-Q · Aug 7, 2025 · 10-Q · Nov 6, 2025
Comparison evidence: 10-Q · Aug 6, 2024 · 10-Q · Nov 5, 2024
Primary evidence: 10-Q · May 8, 2025 · 10-Q · Aug 7, 2025
Comparison evidence: 10-Q · May 7, 2024 · 10-Q · Aug 6, 2024
Primary evidence: 10-Q · May 8, 2025
Comparison evidence: 10-Q · May 7, 2024
Financial-result events require at least a 10% absolute change or a sign/zero transition in supported revenue, operating income, net income, or free cash flow. Quarterly comparisons are same fiscal quarter year over year; annual comparisons use adjacent comparable annual periods.
Share-count events use only consecutive reviewed complete share-count observations. Ownership events require explicit comparable complete beneficial-ownership snapshots; partial incremental ownership reports are never treated as complete positions.
This is a structured change feed, not a general news feed or generated factual narrative. Missing source history can mean that a change is not measurable here.
Margins and growth rates are calculated from the reported financial results shown on this page.
Reviewed wealth records connect this company to major fortunes while keeping company ownership, legal-security positions, voting power, control, and observation dates distinct.
This is reviewed connected-wealth research, not a complete institutional-ownership table.
